Fund Holdings — Pivotal bioVenture Partners Investment Advisor LLC

Total Portfolio Value:
$130.07M
Total Bought:
$1.12M
Total Sold:
$12.01M
Net Transaction:
-$10.90M
Notable People:
Robert Lorne Hopfner, Peter Tuxen Bisgaard, Pivotal Bioventure Partners, Pivotal Partners Ltd
Securities
▲▼
SharesValue
Q1 2024
▲▼
Q2 2024
▲▼
Change
▲▼
Q1 2024
▲▼
Q2 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Vaxcyte, Inc.(PCVX)793,036793,0360$54.17M$59.88M46.04%+$5.71M
Inozyme Pharma Inc4,494,8514,494,8510$34.43M$20.05M15.41%-$14.38M
Oculis Holding AG(OCS)1,595,9181,595,9180$19.23M$19.07M14.66%-$159.6K
Arcutis Biotherapeutics, Inc.(ARQT)2,028,0082,041,108+13,100$20.10M$18.98M14.59%-$1.12M
Exscientia PlcADS770,500770,5000$4.41M$3.93M3.02%-$477.7K
Rallybio Corporation(RLYB)2,404,6442,404,6440$4.45M$3.22M2.48%-$1.23M
Vigil Neuroscience Inc560,595560,5950$1.91M$2.24M1.72%+$330.8K
Bolt Biotherapeutics Inc1,891,4671,891,4670$2.65M$1.42M1.09%-$1.23M
Io Biotech Inc864,197864,1970$1.50M$1.01M0.78%-$484.0K
Aligos Therapeutics Inc743,215743,2150$728.4K$260.1K0.20%-$468.2K
Fusion Pharmaceuticals Inc563,3850-563,385$12.01M$0—-$12.01M
Page 1 of 1
Pivotal bioVenture Partners Investment Advisor LLC — 13F Holdings — Q2 2024 | TickerTrail